Off-label prescribing by psychiatrists

Psychiatric Bulletin

Volumn 30, Issue 2, 2006, Pages 55-57

  Hodgson, Richard ^a   Belgamwar, Ravindra ^a  

^a Bradwell Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; OLANZAPINE; RISPERIDONE; SERTINDOLE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG RESPONSE; FEMALE; FINANCIAL MANAGEMENT; HUMAN; INFORMED CONSENT; LICENCE; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MENTAL DISEASE; MENTAL HEALTH SERVICE; MOOD DISORDER; NEUROSIS; OFF LABEL DRUG USE; ORGANIC BRAIN SYNDROME; PERSONALITY DISORDER; PRACTICE GUIDELINE; PRESCRIPTION; PSYCHIATRIST; SCHIZOPHRENIA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED KINGDOM;

EID: 31744433268     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.30.2.55     Document Type: Article

References (16)

1. ASHCROFT, D. M., FRISCHER, M., LOCKETT, S., et al (2002) Variations in prescribing atypical antipsychotic drugs in primary care: cross-sectional study. Pharmacoepidemiology and Drug Safety, 11, 285-289.
2. BOARDMAN, A. P., HODGSON, R. E., LEWIS, M., et al (1997) Social indicators and the prediction of psychiatric admission in different diagnostic groups. British Journal of Psychiatry, 171, 457-462.
3. BRITISH MEDICAL ASSOCIATION & ROYAL PHARMACEUTICAL SOCIETY (2002) British National Formulary. London & Wallingford: BMJ Bookshop & Pharmaceutical Press.
4. COMMITTEE ON SAFETY OF MEDICINES (2004) Atypical antipsychotic drugs and stroke. http://www.mhra.gov.uk/home/groups/pl-p/documents/ drugsafetymessage/con019488.pdf
5. CONROY, S., CHOONARA, I., IMPICIATORE, P., et al (2000) Survey of unlicensed and off-label drug use in paediatric wards in European countries. BMJ 320, 79-82.
6. CONSUMERS' ASSOCIATION (1992) Prescribing unlicensed drug or using drugs for unlicensed indications. Drug and Therapeutics Bulletin, 30, 97-99.
7. DOUGLAS-HALL, P., FULLER, A. & GILL-BANHAM, S. (2001) An analysis of off-licence prescribing in psychiatric medicine. Pharmaceutical Journal, 267, 890-891.
8. HEALY, D. (2002) The Creation of Psychopharmacology. Cambridge, MA: Harvard University Press.
9. HENRY, V. (1999) Off-label prescribing Legal implications. Journal of Legal Medicine, 20, 365-383.
10. HENRY, V. (1999) Off-label prescribing. Legal implications. Journal of Legal Medicine, 20, 365-383.
11. LENZER, J. (2004) Pfizer pleads guilty, but drug sales continue to soar. BMJ, 328, 1217.
12. LOWE-PONSFORD, F. & BALDWIN, D. (2000) Off-label prescribing by psychiatrists. Psychiatric Bulletin, 24, 415-417.
13. NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (2002) Guidance on the Use of Newer (Atypical) Antipsychotic Drugs for the Treatment of Schizophrenia. London: NICE.
14. McINTYRE, J., CONROY, S., AVERY, A., et al (2000) Unlicensed and off label prescribing of drugs in general practice. Archives of Disease in Childhood, 83, 498-501.
15. SHANNON, C. (2003) Money must be made available for NICE guidance, minister says. BMJ, 327, 1368.
16. WORLD HEALTH ORGANIZATION (1993) The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: WHO.